Dear User,

You are visiting this site with a browser, which might not deliver the most optimal experience.

You are still able to proceed, but in order to best experience this page, we recommend using Edge, Firefox and Chrome.

DELIVERING THE SCIENCE OF TOMORROW

The tides are turning. In a slowly emerging post-pandemic world, the Asia Pacific (APAC) region is becoming a strong player in this ever-evolving world of clinical trials – but how has this been achieved? And what will we expect in the future?

Five recognized experts at the forefront of clinical trial development share their knowledge and experience in a recent DHL hosted seminar focused on the region. Now available to watch again.

Speakers and Presentations

Exploring APAC at the Forefront of Clinical Trials

Leonora Lim - The Host

DHL CSI: VP Life Sciences & Healthcare Sector, Asia Pacific

Diversity and Inclusion in Clinical Trials - It Matters

Malini Raj - The Patient

Director, Australian Pituitary Foundation, Head of Strategy, Multicultural Community Banking – Commonwealth Bank

Trends in Drug Development & Clinical Trial Impacts

Rob Montague - The Sponsor

Head of Global Supply Chain Logistics, GlaxoSmithKline

Assessing the Clinical Trials Landscape in APAC and Beyond

Dr. Sucharita Das - The Scientist

Global Director Regulatory Affairs, Quality Assurance and Compliance, Surgenex LLC

The Future of Clinical Development has Arrived

Sanjay Vyas - The Futurist

Parexel International: EVP India Country Head & Managing Director & SBU Head - Clinical Trials, Supply & Logistics

Panel Discussion

All Speakers

Leonora Lim with four of the speakers convene to take questions from the audience

  • Leonora has over 20 years of logistics experience in servicing specifically the Life Sciences and Healthcare sector, with over a decade spent in DHL. In her current role, she works very closely across all of the DHL business divisions. Collaborating together with these colleagues, she helps to identify, explore and meet customer needs, develop new solutions, and ultimately drive business growth in the sector across Asia Pacific.

    Additionally, she promotes DHL capabilities in the Life Sciences and Healthcare sector through global conferences and at DHL’s annual schedule of customer-centric events across Asia Pacific and in Singapore. Born and raised in Singapore, Leonora holds an Executive Masters in Business Administration from the Singapore Management University.

  • Malini has over 20 years of experience working across several prestigious domestic and international Financial Services organizations. She is currently Head of Strategy for Multicultural Community Banking at the Commonwealth Bank; a role allows her to work in my area of passion on a daily basis – promoting cultural diversity and social cohesion. She consistently advocates for a more diverse workforce/diverse representation in the community and is seen as a strong ambassador/thought-leader for diversity and inclusion at the Commonwealth Bank.

    She is also Chair of CommBank’s Cultural Diversity employee network Mosaic, which is responsible for promoting cultural diversity and inclusion across the Group. She was also responsible for introducing the Corporate Hijab into the CBA Corporate Wardrobe for Muslim Women Employees. She has a strong interest in making a social impact, reflected her roles in the Department of Prime Minister and Cabinet’s Advisory Group on Preventing Financial Abuse of Women, Finsia Diversity Advisory Council (previous Non-Executive Director), FECCA Women’s Advisory Group, Women’s on Boards Cultural Diversity Advisory Group, and volunteer at the Starlight Foundation for the last 9 years.

    She is a strong patient advocate for Cushing’s disease being a patient herself, diagnosed in 2013 after a 20-year journey to diagnosis. She is a Non-Executive Director of the Australian Pituitary Foundation (previous Chair), Member of the World Alliance of Pituitary Organisations (previous Non-Executive Director and Treasurer), and is on the Paraxel Patient Advisory Group to provide advice on how to increase diversity in clinical trials and in particular ethnic minority groups who are often under-represented. She is passionate about sharing her personal story and experience to create awareness, provide support and drive change domestically and globally, having spoken at conferences in London, Amsterdam, Sydney, and Venice.

  • Rob Montague is currently the Head of Global Supply Chain Logistics for GSK’s R&D unit, where he is responsible for the Global Distribution and Cross Border Compliance of the investigational product for GSK’s Pharmaceutical development portfolio. In the four years since moving to R&D, Rob led a global harmonization initiative, implemented a global in-transit temperature monitoring process, and improved the organization’s on-time performance. Equally, he has improved R&D Cross Border compliance and implemented a number of duty deferral/duty reclaim programs.

    Rob is an experienced Supply Chain professional with the majority of his career in the Pharmaceutical environment. Prior to moving to R&D, Rob held various senior positions, including leading Production Planning and Warehousing Operations for Commercial Production and leading the US Finished Goods Distribution Group. Rob has worked globally in the Import/Export Cross Border Compliance area leading the US and UK Import/Export teams.

    Additionally, Rob led the Global Distribution and Warehousing Shared Service, which initiated a redesign of the European physical supply chain and reduced 27 distribution facilities down to four.

    Rob holds a Bachelor of Science degree in Transportation and Logistics.

  • Dr. Das has worked with MNCs as Regional Head of APAC for companies such as Pfizer, Covance, Nobel Biocare and Allergan. She has over 18 years of experience in leading the APAC region in Regulatory affairs (Regulatory Affairs Strategy/Submissions/Compliance) and Quality assurance for Pharmaceutical/Biological/OTC products, Medical devices/Biotech, Cosmetics and clinical trials in both USA and European MNCs. 

    Registered Class 1 to 3 medical devices and supported GDPMDS/GDP/GCP/GMP audits across Asia Pacific. Member of ACCSQMDPWG(ASEAN consultative committee for standards and quality medical device product working group). Worked closely with health authorities in the APAC region (CFDA/HSA/TGA/TFDA/PFDA etc).

  • Having recently moved from USA as the India Country Head & Board of Director, he is responsible to develop strategic direction & provide the leadership and vision necessary to grow the 5,400 plus India organization. He also heads Parexel’s Global Clinical supplies & Logistics business which also includes the global distributions centers & infrastructure. 

    Previously at DHL as the VP for Life Sciences and Healthcare APAC, based in Singapore he was responsible to manage the Global Logistics & Supply Chain business for the top Life Science & Healthcare Customers across all DHL BU’s within APAC. He was a member of the DHL Life Sciences and Healthcare Board. Sanjay holds a Master’s Degree in Marketing Management & a Bachelor’s Degree in Commerce & Economics. He also has a Professional Diploma in Software Technology and Systems Management.

    Sanjay Vyas has lived & worked in 8 countries and 4 continents, and brings over 23+ years of experience in Global P&L management, Logistics & Supply chain management, Sales & Marketing, M&A's, Operations & People management.


Upcoming Life Sciences & Healthcare Events & Webinars

Browse our guide to find your next DHL event or webinar. We look forward to welcoming you!

Sector ExpertiseFind out more about

Insights and solutions created specifically for your industry

Products & SolutionsFind out more about

Products and solutions that will maximise your logistics operations